Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
about
Inhibition of PI3K/Akt/mTOR overcomes cisplatin resistance in the triple negative breast cancer cell line HCC38.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@en
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@nl
type
label
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@en
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@nl
prefLabel
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@en
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@nl
P2093
P2860
P1433
P1476
Inhibition of PI3K/Akt/mTOR ov ...... breast cancer cell line HCC38.
@en
P2093
Alexandra Hamacher
Katharina Gohr
Laura H Engelke
Matthias U Kassack
P2860
P2888
P356
10.1186/S12885-017-3695-5
P407
P577
2017-11-03T00:00:00Z
P6179
1092517239